CONTINUOUS MICRODOSING Trademark

Trademark Overview


On Wednesday, May 18, 2016, a trademark application was filed for CONTINUOUS MICRODOSING with the United States Patent and Trademark Office. The USPTO has given the CONTINUOUS MICRODOSING trademark a serial number of 87041834. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, July 2, 2018. This trademark is owned by Alimera Sciences, Inc.. The CONTINUOUS MICRODOSING trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:

Drug delivery agents consisting of polymer compounds that facilitate the delivery of pharmaceuticals for the treatment of macular edema, macular disease, retinal disease, glaucoma, and ocular allergy; pharmaceutical preparations for the treatment and prevention of macular edema, macular disease, retinal disease, glaucoma, and ocular allergy

Medical apparatus and units for dosage, measuring and monitoring, namely, sustained drug delivery systems for ocular drugs; medical devices and apparatus, namely, surgical implants comprised primarily of artificial material and also incorporating processed animal tissue for use in plastic reconstructive surgery, and repair, reinforcement or buttressing of soft tissue, and parts and fittings therefor
continuous microdosing

General Information


Serial Number87041834
Word MarkCONTINUOUS MICRODOSING
Filing DateWednesday, May 18, 2016
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateMonday, July 2, 2018
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesDrug delivery agents consisting of polymer compounds that facilitate the delivery of pharmaceuticals for the treatment of macular edema, macular disease, retinal disease, glaucoma, and ocular allergy; pharmaceutical preparations for the treatment and prevention of macular edema, macular disease, retinal disease, glaucoma, and ocular allergy
Goods and ServicesMedical apparatus and units for dosage, measuring and monitoring, namely, sustained drug delivery systems for ocular drugs; medical devices and apparatus, namely, surgical implants comprised primarily of artificial material and also incorporating processed animal tissue for use in plastic reconstructive surgery, and repair, reinforcement or buttressing of soft tissue, and parts and fittings therefor

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, May 24, 2016
Primary Code005
First Use Anywhere DateWednesday, July 20, 2016
First Use In Commerce DateWednesday, July 20, 2016

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateTuesday, May 24, 2016
Primary Code010
First Use Anywhere DateWednesday, July 20, 2016
First Use In Commerce DateWednesday, July 20, 2016

Trademark Owner History


Party NameAlimera Sciences, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressAlpharetta, GA 30005

Trademark Events


Event DateEvent Description
Monday, July 2, 2018ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Monday, July 2, 2018ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Monday, December 4, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, December 4, 2017NON-FINAL ACTION E-MAILED
Monday, December 4, 2017NON-FINAL ACTION WRITTEN
Friday, October 13, 2017NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Thursday, October 12, 2017USE AMENDMENT ACCEPTED
Wednesday, September 20, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, September 20, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, September 20, 2017TEAS REQUEST FOR RECONSIDERATION RECEIVED
Wednesday, September 20, 2017AMENDMENT TO USE PROCESSING COMPLETE
Wednesday, September 20, 2017USE AMENDMENT FILED
Tuesday, September 19, 2017TEAS AMENDMENT OF USE RECEIVED
Wednesday, April 5, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, April 5, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, April 4, 2017NOTIFICATION OF FINAL REFUSAL EMAILED
Tuesday, April 4, 2017FINAL REFUSAL E-MAILED
Tuesday, April 4, 2017FINAL REFUSAL WRITTEN
Saturday, March 11, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, March 9, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 9, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, September 9, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, September 9, 2016NON-FINAL ACTION E-MAILED
Friday, September 9, 2016NON-FINAL ACTION WRITTEN
Friday, September 2, 2016ASSIGNED TO EXAMINER
Tuesday, May 24, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, May 21, 2016NEW APPLICATION ENTERED IN TRAM